Ness Ziona, Israel

Yoram Reiter


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yoram Reiter: Innovator in Protease-Activatable Pseudomonas Exotoxin A-like Proproteins

Introduction

Yoram Reiter is a notable inventor based in Ness Ziona, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of protease-activatable pseudomonas exotoxin A-like proproteins. With a total of 2 patents, his work has the potential to impact therapeutic applications significantly.

Latest Patents

Yoram Reiter's latest patents focus on innovative proproteins that are designed to target and kill specific cells. The first patent describes protease-activatable Pseudomonas exotoxin A-like proproteins, which include a cell recognition domain, a modified PE translocation domain, and a cytotoxicity domain. These components work together to ensure effective translocation to the cell cytosol upon proteolytic cleavage. The second patent similarly outlines polynucleotides encoding these proproteins, emphasizing their potential for targeted cell destruction.

Career Highlights

Yoram Reiter is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this capacity has allowed him to collaborate on groundbreaking research that bridges the gap between basic science and clinical applications.

Collaborations

Yoram has worked alongside esteemed colleagues such as David J FitzGerald and Ira H Pastan. Their combined expertise has contributed to the advancement of research in the field of protease-activatable toxins.

Conclusion

Yoram Reiter's innovative work in the development of protease-activatable pseudomonas exotoxin A-like proproteins showcases his commitment to advancing biotechnology. His contributions are poised to make a significant impact in therapeutic applications, highlighting the importance of innovation in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…